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http://intl.elsevierhealth.com/journals/ijidDifficulties in the diagnosis of delayed contral-
ateral hemiparesis due to Varicella-Zoster Virus
in an HIV-positive patient
Herpes zoster is much more frequent among HIV-infected
patients compared to immunocompetent populations.1
Delayed contralateral hemiparesis (DCH) is a rare but serious
complication that can occur weeks to months after an epi-
sode of herpes zoster ophthalmicus (HZO).1 Previous vari-
cella-zoster virus (VZV) infection could be associated with
the pathomechanism in cases of central nervous system (CNS)
involvement, despite negative VZV-DNA in PCR of the cere-
brospinal fluid (CSF).2 Herein, we describe the case of an HIV-
positive patient who developed left hemiparesis due to
cerebral angiitis, as evident from MRI images, four months
after HZO on the right side.
A 32-year-old HIV-positivemale developed left hemiparesis
four months after HZO on the right side. At that time, he was
treatedwith acyclovir (10 mg/kg/q 8 hr, intravenously, for ten
days). He had begun highly active antiretroviral therapy
(HAART; zidovudine/lamivudine/lopinavir plus ritonavir) two
weeksbefore themost recentadmission.His lymphocyteTCD4
cell count was 59 cells/ml (3%) and the HIV viral loadwas>500
000 copies/ml. Serology markers for toxoplasmosis, Chagas
disease, hepatitis B and hepatitis C infection were negative,
including the venereal disease research laboratory (VDRL)
test. Serum VZV IgG was positive, but negative for VZV IgM,
both by inmunofluorescence assay (IFA) performed on VZV
antigen slides (BION Enterprises, IL, USA). For the IgG assay,
a second antibody was fluorescein isothiocyanate (FITC)-con-
jugated rabbit anti-human IgG, specific for gamma chains
(DAKO, Denmark). For the IgM assay, a second antibody was
FITC-conjugated rabbit anti-human IgM, specific for mu chains
(DAKO, Denmark). The CSF revealed 5 mononuclear cells/
mm3, protein level 0.35 mg/dl, glucose level 56 mg/dl;
Ziehl—Neelsen, Indian ink and Gram stains were negative.
Multiplex herpesvirus (MHV) PCR for herpes simplex virus
(HSV) 1/2, VZV, cytomegalovirus (CMV), Epstein—Barr virus
(EBV) and humanherpes virus-type6DNA (Herplex,Genomica,
Spain) was performed on the CSF, all giving a negative result.
No antibodies for VZVwere found in the CSF by IFA. A contrast-
enhanced cerebral CTscan did not disclose abnormalities. An
ischemic lesion in the right parieto-occipital area and an
uncharacteristic low signal intensity on T2-weighted images
of the subcortical temporo-occipital lobes, with extension to
the right semioval center and corona radiata, could be1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.12.006detected by gadolinium-delayed enhancement of MRI. MRI
angiography showedmultiple segmental narrowing of the right
internal carotid and vertebral arteries, and a stop in the
rolandic artery (Figure 1). There was lack of opacification in
the sylvian branches and no contrast enhancement of the
parietal and occipital lobes on the same side. A diagnosis of
VZV-associated granulomatous vasculitis was made. Intrave-
nous acyclovir (10 mg/kg tid) plus prednisolone (60 mg qd,
gradually diminishing) was administered for three weeks. On
day 21, all treatments were withdrawn and the patient was
discharged. The hemiparesis gradually healed, with kinetic
rehabilitation during the 12-month follow-up period, with
concurrent angiographic pattern improvement.
The pathogenesis of this syndrome is thought to be due to
either direct VZV invasion of the cerebral arteries by exten-
sion along the intracranial branches of the trigeminal nerve
or virion spread through the circulatory system, resulting in
inflammation of the internal carotid artery or one of its
branches on the side ipsilateral to the rash.1 Aneurysmal
lesions reported in the literature showed distribution from
the proximal to the distal cerebral arteries. These charac-
teristics suggest that the spread of VZV occurs through the
cerebral arteries and not through the trigeminal nerve.3
At onset, the typical presentation includes headache and
hemiplegiaoccurring inapatientwitha recenthistoryofHZO,1
as in the case we present. MRI commonly demonstrated wide-
spread lesions, consistent with the ischemic lesion in the right
parieto-occipital area shown in this patient. The multiple
segmental vascular narrowing observed in the cerebral angio-
graphy of our patient is in keeping with granulomatous vascu-
litis, as described in the literature.4
Examination of CSF in cases of CNS vasculitis often reveals
mononuclear cell pleocytosis and increased protein levels,1
conditions that did not occur in our case.
The sensitivity of a multiplex-nested PCR assay for the
simultaneous detection of five human herpesviruses (CMV,
EBV, VZV, HSV-1/2 and HHV-6) in CSF has been reported to be
high for CMV, but was not evaluable for VZV disease, because
of the small number of patients.5 In our experience with the
MHV technique, VZV was detected in the CSF of 4 AIDS
patients out of 30 with neurological symptoms; in all cases,
the diagnosis was meningitis with cutaneous zoster.6
When CSF shows normal parameters, the PCR VZV test
result is negative, whereas few cases of CSF with altered
values show positive PCR.7 Although PCR could not detect
VZV-DNA in CSF, previous VZV infection might be closelyPublished by Elsevier Ltd. All rights reserved.
Figure 1 MRI angiography showing multiple segmental narrow-
ing of the right internal carotid and vertebral arteries, and a stop
in the rolandic artery (black arrow). There is also lack of
opacification in the sylvian branches (white arrows).
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Gilden et al. have documented a low sensitivity for PCR in the
setting of subacute or chronic CNS VZV infection, and have
stressed that intrathecal synthesis of VZV-specific antibodies
might be a more reliable diagnostic measure in such cases,
particularly with intervals of weeks to months between
zoster and onset of neurological disease.8 In this way, IgG
anti-VZV intrathecal synthesis was not detected in our
patient. Normally, intrathecally synthesized IgG antibodies
are measured in the post-acute stage of disease and persist
for several years, although the intrathecal immune response
might be delayed or absent when antiviral treatment is
started early.9,10 The clinical deficits and vasculitic MRI
changes commonly regressed with antiviral and immunosup-
pressive therapy.4 Complete recovery was achieved in this
patient after the antiviral scheme was established, although
a mortality rate of 20—25%, with a high probability of per-
manent neurologic sequelae among survivors, has been pub-
lished in the literature.1
Opportunistic infections, such as fungi, syphilis, herpes
zoster, septic arteritis in bacterial endocarditis and direct
HIV effects on endothelial cells, are recorded among the
etiologies of infectious vasculitis in the CNS of patients with
HIV infection.11 None of these were present in our patient,
except for herpes zoster and HIV. VZV, CMV and Treponema
pallidum are known to cause vasculitis in the CNS in the
absence of systemic manifestations of the primary disease.
Direct effects of the retrovirus as the source of vasculitis
were estimated when no specific antibodies for these infec-
tions were present in the CSF,12 although no accurate diag-
nosis was performed in these cases.
Inconclusion,diagnosingDCHcanbedifficult in theabsence
of VZV-DNA in CSF, until new technologies, such as real-time
PCR with higher sensitivity, are evaluated with regard to VZV-
associated syndromes. Patient records, clinical presentation,
response to specific antiviral therapy and, mainly, the angio-
graphy images should be taken into account in the diagnosis of
VZV-associated cerebral vasculitis in HIV patients.
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